Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 4 | 2020 | 223 | 1.240 |
Why?
|
| Drug Delivery Systems | 8 | 2019 | 669 | 1.200 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2018 | 31 | 1.010 |
Why?
|
| Cornea | 5 | 2017 | 638 | 0.990 |
Why?
|
| Eye | 2 | 2017 | 301 | 0.950 |
Why?
|
| Delayed-Action Preparations | 5 | 2019 | 208 | 0.870 |
Why?
|
| Nanotechnology | 2 | 2015 | 137 | 0.820 |
Why?
|
| Bioprinting | 1 | 2020 | 7 | 0.780 |
Why?
|
| Microtechnology | 2 | 2011 | 12 | 0.760 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 129 | 0.720 |
Why?
|
| Cysteamine | 1 | 2016 | 15 | 0.580 |
Why?
|
| Cystinosis | 1 | 2016 | 16 | 0.580 |
Why?
|
| Dexamethasone | 3 | 2017 | 1450 | 0.570 |
Why?
|
| Polyglycolic Acid | 3 | 2011 | 34 | 0.560 |
Why?
|
| Particle Size | 3 | 2011 | 182 | 0.560 |
Why?
|
| Biosensing Techniques | 2 | 2007 | 75 | 0.550 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2015 | 18 | 0.540 |
Why?
|
| Dry Eye Syndromes | 2 | 2016 | 286 | 0.510 |
Why?
|
| Nanostructures | 3 | 2016 | 94 | 0.490 |
Why?
|
| Lactic Acid | 3 | 2011 | 305 | 0.480 |
Why?
|
| Hydrogels | 2 | 2010 | 123 | 0.420 |
Why?
|
| Drug Carriers | 3 | 2010 | 327 | 0.410 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 461 | 0.410 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 152 | 0.320 |
Why?
|
| Homocystine | 1 | 2008 | 2 | 0.320 |
Why?
|
| Immunomagnetic Separation | 1 | 2007 | 43 | 0.310 |
Why?
|
| Ophthalmic Solutions | 2 | 2019 | 101 | 0.310 |
Why?
|
| Bioterrorism | 1 | 2007 | 13 | 0.300 |
Why?
|
| Anthrax | 1 | 2007 | 36 | 0.290 |
Why?
|
| Bacillus anthracis | 1 | 2007 | 44 | 0.290 |
Why?
|
| Biocompatible Materials | 2 | 2018 | 202 | 0.280 |
Why?
|
| Adenosine | 1 | 2008 | 289 | 0.270 |
Why?
|
| Bacteriological Techniques | 1 | 2006 | 121 | 0.260 |
Why?
|
| Nanoparticles | 1 | 2009 | 554 | 0.250 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 663 | 0.250 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 233 | 0.240 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 862 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 6942 | 0.200 |
Why?
|
| Platelet Factor 4 | 1 | 2021 | 35 | 0.200 |
Why?
|
| CD8 Antigens | 1 | 2021 | 170 | 0.190 |
Why?
|
| CD4 Antigens | 1 | 2021 | 170 | 0.190 |
Why?
|
| Posterior Eye Segment | 1 | 2019 | 3 | 0.180 |
Why?
|
| Animals | 10 | 2021 | 59536 | 0.170 |
Why?
|
| Stents | 1 | 2006 | 1096 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2007 | 2022 | 0.170 |
Why?
|
| Leydig Cells | 1 | 2018 | 39 | 0.160 |
Why?
|
| Polyesters | 1 | 2018 | 53 | 0.160 |
Why?
|
| Hernia, Ventral | 1 | 2020 | 159 | 0.160 |
Why?
|
| Polyvinyl Alcohol | 1 | 2017 | 19 | 0.150 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2017 | 21 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 135 | 0.150 |
Why?
|
| Retinal Diseases | 1 | 2019 | 179 | 0.150 |
Why?
|
| Cystine | 1 | 2016 | 34 | 0.140 |
Why?
|
| Eye Burns | 1 | 2016 | 19 | 0.140 |
Why?
|
| Burns, Chemical | 1 | 2016 | 34 | 0.140 |
Why?
|
| Biomarkers | 1 | 2007 | 5047 | 0.140 |
Why?
|
| Drug Liberation | 1 | 2015 | 12 | 0.130 |
Why?
|
| Corneal Neovascularization | 1 | 2015 | 14 | 0.130 |
Why?
|
| Diffusion | 1 | 2015 | 88 | 0.130 |
Why?
|
| Mice | 6 | 2021 | 34495 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 702 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 1586 | 0.110 |
Why?
|
| Indazoles | 1 | 2015 | 297 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 6086 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 661 | 0.090 |
Why?
|
| Phase Transition | 1 | 2009 | 17 | 0.090 |
Why?
|
| Kinetics | 2 | 2010 | 2049 | 0.090 |
Why?
|
| Silicon | 1 | 2009 | 48 | 0.090 |
Why?
|
| Gelatin | 1 | 2009 | 49 | 0.090 |
Why?
|
| Wound Healing | 1 | 2015 | 815 | 0.090 |
Why?
|
| Materials Testing | 1 | 2009 | 116 | 0.090 |
Why?
|
| Escherichia coli O157 | 1 | 2009 | 5 | 0.090 |
Why?
|
| Food Microbiology | 1 | 2009 | 26 | 0.090 |
Why?
|
| Image Cytometry | 1 | 2009 | 47 | 0.090 |
Why?
|
| Imidazoles | 1 | 2015 | 999 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2009 | 629 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2008 | 515 | 0.080 |
Why?
|
| Paclitaxel | 2 | 2008 | 1996 | 0.080 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 105 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 44 | 0.080 |
Why?
|
| Micelles | 1 | 2008 | 34 | 0.080 |
Why?
|
| Magnetics | 1 | 2009 | 107 | 0.080 |
Why?
|
| Acrylates | 1 | 2008 | 30 | 0.080 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2007 | 56 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 83 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2008 | 186 | 0.080 |
Why?
|
| Equipment Design | 1 | 2011 | 1204 | 0.070 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 49 | 0.070 |
Why?
|
| Niacinamide | 1 | 2008 | 421 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 2809 | 0.070 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 63 | 0.070 |
Why?
|
| Optics and Photonics | 1 | 2007 | 146 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2006 | 334 | 0.070 |
Why?
|
| Swine | 1 | 2009 | 1541 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 1489 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 380 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 852 | 0.060 |
Why?
|
| Female | 5 | 2021 | 141928 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 3203 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 56 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2016 | 32848 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 1479 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 4233 | 0.050 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 100 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 276 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2006 | 1203 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 6089 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4757 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2019 | 257 | 0.040 |
Why?
|
| Cells, Immobilized | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 905 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 11538 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 164 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 229 | 0.040 |
Why?
|
| Alkalies | 1 | 2016 | 32 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 15694 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 607 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 345 | 0.030 |
Why?
|
| Solubility | 2 | 2008 | 242 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2018 | 269 | 0.030 |
Why?
|
| Time Factors | 1 | 2008 | 12926 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 4307 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 629 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3821 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 3045 | 0.030 |
Why?
|
| Humans | 5 | 2021 | 261506 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5637 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.020 |
Why?
|
| Sodium Salicylate | 1 | 2008 | 6 | 0.020 |
Why?
|
| Intestinal Secretions | 1 | 2008 | 6 | 0.020 |
Why?
|
| Gastric Juice | 1 | 2008 | 19 | 0.020 |
Why?
|
| Polysorbates | 1 | 2008 | 25 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 195 | 0.020 |
Why?
|
| Drug Stability | 1 | 2008 | 105 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2008 | 84 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2008 | 70 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 585 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 14551 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 1544 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 7222 | 0.010 |
Why?
|
| Male | 1 | 2018 | 123000 | 0.000 |
Why?
|